Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01358877
Brief Title: A Study of Pertuzumab in Addition to Chemotherapy and Trastuzumab as Adjuvant Therapy in Participants With Human Epidermal Growth Receptor 2 (HER2)-Positive Primary Breast Cancer (APHINITY)

First Submitted : May 20, 2011
First Submitted that Met QC Criteria : May 20, 2011
First Posted : May 24, 2011 (Estimate)

Results First Submitted : December 4, 2017
Results First Submitted that Met QC Criteria : December 4, 2017
Results First Posted : January 5, 2018

Last Update Submitted that Met QC Criteria : February 25, 2019
Last Update Posted : February 27, 2019